Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research.
Catena Biosciences has raised $2.4M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
Catena Biosciences's investors include Y Combinator, Gaingels, Caffeinated Capital, Pioneer Fund, Civilization Ventures.
Catena Biosciences is headquartered in Berkeley, United States.
Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research.
Catena Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Catena Biosciences — Funding & Investors." VCBacked, May 10, 2024, https://www.vcbacked.co/company/catena-biosciences. Accessed July 20, 2026.
VCBacked. (2024). Catena Biosciences — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/catena-biosciences
{{cite web |title=Catena Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/catena-biosciences |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated